MedTrace Logo

MRI Assessment of Impaired Glucose Metabolism in Alzheimer's Disease

NCT05402566 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 21

Last updated 2023-12-01

No results posted yet for this study

Summary

Diseases of dementia are chronic, untreatable, and cause a massive burden of morbidity. In this proposal, we seek to tackle the problem of better, earlier, and more efficient diagnosis using deuterium metabolic imaging (DMI). The study is divided in two sub-studies: 1) optimization and simplification of DMI protocols, and 2) a cross-sectional study of DMI in Alzheimer's patients and healthy controls.

Conditions

  • Alzheimer Disease

Interventions

DIAGNOSTIC_TEST

Deuterium metabolic imaging

MRI after oral administration of 75g of \[6,6'-2H2\]glucose.

Sponsors & Collaborators

  • Aarhus University Hospital

    collaborator OTHER

  • University of Aarhus

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-22
Primary Completion
2023-10-27
Completion
2023-10-27

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05402566 on ClinicalTrials.gov